StockIQ.techMonte Rosa Therapeutics, Inc. (GLUE) Stock Analysis
Free AI-powered analysis and research for Monte Rosa Therapeutics, Inc. stock
Sector: Healthcare
Full GLUE report
Monte Rosa Therapeutics, Inc. (GLUE) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze GLUE Now →📰 Latest Update
Wall Street Analysts See a 152.87% Upside in Monte Rosa Therapeutics (GLUE): Can the Stock Really Move This High?
Tue, November 3, 2026 at 1:55 PM UTC 3 min read
Monte Rosa Therapeutics (GLUE) has seen a 3.5% increase in its stock price over the past month, closing at $10.63. Wall Street analysts project a mean price target of $26.88, suggesting a potential upside of 152.9%, with estimates ranging from $19.00 to $37.00. Despite the optimistic outlook, the article cautions that investors should approach price targets with skepticism, as they may not accurately reflect future stock movements, although recent positive earnings estimate revisions could indicate potential growth.